These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 16369949)
21. Tumor-targeting of viral vectors for cancer gene therapy by using antibodies or their genes against tumor-associated antigens. Kuroki M; Kuroki M; Shibaguchi H; Hachimine K; Kinugasa T; Badran A Anticancer Res; 2004; 24(5C):3373-7. PubMed ID: 15515434 [TBL] [Abstract][Full Text] [Related]
22. Experimental strategies in gene therapy of cancer. Alexandrova R J BUON; 2009 Sep; 14 Suppl 1():S23-32. PubMed ID: 19785067 [TBL] [Abstract][Full Text] [Related]
23. Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes. McNeish IA; Bell SJ; Lemoine NR Gene Ther; 2004 Mar; 11(6):497-503. PubMed ID: 14762396 [TBL] [Abstract][Full Text] [Related]
24. Bacterial vectors and delivery systems in cancer therapy. Gardlik R; Fruehauf JH IDrugs; 2010 Oct; 13(10):701-6. PubMed ID: 20878592 [TBL] [Abstract][Full Text] [Related]
25. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis. Dorer DE; Nettelbeck DM Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376 [TBL] [Abstract][Full Text] [Related]
26. Gene therapy strategies to enhance the effectiveness of cancer radiotherapy. Freyta SO; Kim JH; Brown SL; Barton K; Lu M; Chung M Curr Opin Mol Ther; 2004 Oct; 6(5):513-24. PubMed ID: 15537053 [TBL] [Abstract][Full Text] [Related]
27. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620 [TBL] [Abstract][Full Text] [Related]
28. Cancer gene therapy: challenges and opportunities. Scanlon KJ Anticancer Res; 2004; 24(2A):501-4. PubMed ID: 15152950 [TBL] [Abstract][Full Text] [Related]
29. Gene therapy for head and neck cancer. Harrington KJ; Nutting CM; Pandha HS Cancer Metastasis Rev; 2005 Jan; 24(1):147-64. PubMed ID: 15785878 [TBL] [Abstract][Full Text] [Related]
30. Targeting gene-virotherapy of cancer and its prosperity. Liu XY Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812 [TBL] [Abstract][Full Text] [Related]
31. Gene therapy in ocular diseases. Singh VK; Tripathi P Indian J Ophthalmol; 2002 Sep; 50(3):173-81. PubMed ID: 12355690 [TBL] [Abstract][Full Text] [Related]
32. Bacteria in gene therapy: bactofection versus alternative gene therapy. Pálffy R; Gardlík R; Hodosy J; Behuliak M; Resko P; Radvánský J; Celec P Gene Ther; 2006 Jan; 13(2):101-5. PubMed ID: 16163379 [TBL] [Abstract][Full Text] [Related]
33. Gene therapy developments for pancreatic cancer. Bhattacharyya M; Lemoine NR Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328 [TBL] [Abstract][Full Text] [Related]
34. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies. Papadopoulos N; Kinzler KW; Vogelstein B Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147 [TBL] [Abstract][Full Text] [Related]
35. The genus Bifidobacterium for cancer gene therapy. Fujimori M; Amano J; Taniguchi S Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126 [TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of small interfering RNA: approaching effective cancer therapies. Pirollo KF; Chang EH Cancer Res; 2008 Mar; 68(5):1247-50. PubMed ID: 18316585 [TBL] [Abstract][Full Text] [Related]